BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 19, 2018
View Archived Issues
Kiss of death: tumor cells suck calcium from bone cells to metastasize
Read More
Data presented on BRM-inhibiting ureas as potential anticancer agents
Read More
Phase II trial explores whether EDP-1503 enhances response to pembrolizumab in advanced melanoma
Read More
PDE9 inhibition with CRD-733 shows promise for heart failure
Read More
SY-5609 selected for development from novel selective CDK7 inhibitor series
Read More
COQ8B acts as a modifier of thoracic aortic aneurysm severity
Read More
Microbiome-derived butyrate builds bone
Read More
Giving herpesviruses a TRIM
Read More
How malaria drugs fight cancer
Read More
Assembly Biosciences initiates first-in-human study of ABI-H2158
Read More
Promentis Pharmaceuticals completes phase I studies of SXC-2023
Read More
Hummingbird Bioscience presents unique mechanism of action for novel anti-HER3 antibody
Read More
FDA grants approval for Adcetris as first-line treatment for peripheral T-cell lymphoma
Read More
Promacta granted FDA approval for first-line SAA and breakthrough therapy designation for H-ARS
Read More
Japanese researchers patent compounds for fibrosis
Read More
Takeda Pharmaceutical presents CaS antagonists
Read More
FDA approves Aemcolo for the treatment of travelers' diarrhea
Read More
FDA approves IND for first-in-human study of GZ17-6.02
Read More
Chemotherapeutic agents reactivate HBV via ribophorin II downregulation
Read More
Bridge Biotherapeutics files IND for BBT-877
Read More
Bifunctional agent N-809 demonstrates effective cancer immunotherapeutic properties
Read More
First patient enrolled in a phase III study of clonidine micropellet for sciatica
Read More
First results presented with RNAi ARO-HBV in chronic HBV infection
Read More
First phase II data presented for IL-22 agonist F-652 in patients with alcoholic hepatitis
Read More
Proteostasis Therapeutics patents mutant CFTR correctors
Read More
Merck KGaA and Pfizer provide update on JAVELIN ovarian cancer program of avelumab
Read More